• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于纳米技术的药物传递系统用于靶向、成像和诊断神经退行性疾病。

Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.

机构信息

Faculty of Pharmacy, Department of Pharmaceutical Technology, Hacettepe University, 06100 Ankara, Turkey.

出版信息

Pharm Res. 2013 Oct;30(10):2499-511. doi: 10.1007/s11095-013-1156-7.

DOI:10.1007/s11095-013-1156-7
PMID:23959851
Abstract

Neurodegenerative disorders are becoming prevalent with the increasing age of the general population. A number of difficulties have emerged for the potential treatment of neurodegenerative diseases, as these disorders may be multi systemic in nature. Due to limitations regarding the blood brain barrier (BBB) structure, efflux pumps and metabolic enzyme expression, conventional drug delivery systems do not provide efficient therapy for neurodegenerative disorders. Nanotechnology can offer impressive improvement of the neurodegenerative disease treatment by using bio-engineered systems interacting with biological systems at a molecular level. This review focuses on the nano-enabled system applications for the treatment and diagnosis of neurodegenerative diseases, in particular Alzheimer’s, Parkinson’s and Prion diseases.

摘要

神经退行性疾病随着人口老龄化的加剧变得越来越普遍。由于血脑屏障 (BBB) 结构、外排泵和代谢酶表达的限制,传统的药物输送系统不能为神经退行性疾病提供有效的治疗。纳米技术可以通过使用与生物系统在分子水平上相互作用的生物工程系统,为神经退行性疾病的治疗提供显著的改善。本文综述了纳米技术在治疗和诊断神经退行性疾病,特别是阿尔茨海默病、帕金森病和朊病毒病方面的应用。

相似文献

1
Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.基于纳米技术的药物传递系统用于靶向、成像和诊断神经退行性疾病。
Pharm Res. 2013 Oct;30(10):2499-511. doi: 10.1007/s11095-013-1156-7.
2
Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.基于纳米技术的神经退行性疾病靶向治疗:神经药物高效递送的有前途工具。
Curr Drug Targets. 2020;21(8):819-836. doi: 10.2174/1389450121666200106105633.
3
Nanotechnological applications for the treatment of neurodegenerative disorders.用于治疗神经退行性疾病的纳米技术应用。
Prog Neurobiol. 2009 Aug;88(4):272-85. doi: 10.1016/j.pneurobio.2009.05.002. Epub 2009 May 30.
4
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.脂质纳米载体辅助递药治疗神经退行性疾病的最新研究进展。
Eur J Pharm Biopharm. 2020 Apr;149:192-217. doi: 10.1016/j.ejpb.2020.01.005. Epub 2020 Jan 23.
5
Advances in the treatment of neurodegenerative disorders employing nanotechnology.采用纳米技术治疗神经退行性疾病的新进展。
Ann N Y Acad Sci. 2010 Jan;1184:154-72. doi: 10.1111/j.1749-6632.2009.05108.x.
6
Nanotechnology for neurodegenerative disorders.纳米技术治疗神经退行性疾病。
Nanomedicine. 2012 Sep;8 Suppl 1:S51-8. doi: 10.1016/j.nano.2012.05.007. Epub 2012 May 26.
7
Advances in the treatment of neurodegenerative disorders employing nanoparticles.利用纳米颗粒治疗神经退行性疾病的进展。
Recent Pat Drug Deliv Formul. 2012 Apr 1;6(1):2-18. doi: 10.2174/187221112799219125.
8
Application of nanodiagnostics and nanotherapy to CNS diseases.应用纳米诊断和纳米疗法治疗中枢神经系统疾病。
Nanomedicine (Lond). 2018 Sep;13(18):2341-2371. doi: 10.2217/nnm-2018-0163. Epub 2018 Aug 8.
9
Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?用于靶向脑内药物递送的纳米颗粒:我们了解多少?
Int J Mol Sci. 2021 Oct 28;22(21):11654. doi: 10.3390/ijms222111654.
10
Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.中枢神经系统递送神经退行性疾病治疗药物面临的挑战与机遇。
Expert Opin Drug Deliv. 2009 Mar;6(3):211-25. doi: 10.1517/17425240902758188.

引用本文的文献

1
Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer's Disease Targeting.用于增强阿尔茨海默病靶向性的载美金刚胺脂质体的合成与表征
Pharmaceutics. 2025 Feb 17;17(2):267. doi: 10.3390/pharmaceutics17020267.
2
Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review.纳米材料作为克服血脑屏障的药物递送剂:综述
ADMET DMPK. 2023 Oct 31;12(1):63-105. doi: 10.5599/admet.2043. eCollection 2024.
3
How Precise are Nanomedicines in Overcoming the Blood-Brain Barrier? A Comprehensive Review of the Literature.

本文引用的文献

1
Neurodegenerative diseases: Novel route to neuroprotection.神经退行性疾病:神经保护的新途径。
Nat Rev Drug Discov. 2012 Dec;11(12):906-7. doi: 10.1038/nrd3899.
2
Targeted imaging of activated caspase-3 in the central nervous system by a dual functional nano-device.双功能纳米装置对中枢神经系统中活化的 caspase-3 的靶向成像。
J Control Release. 2012 Oct 28;163(2):203-10. doi: 10.1016/j.jconrel.2012.09.001. Epub 2012 Sep 8.
3
Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS.用于将治疗剂可控且增强地递送至中枢神经系统的聚合物纳米载体。
纳米药物在克服血脑屏障方面有多精确?文献综述。
Int J Nanomedicine. 2024 Mar 8;19:2441-2467. doi: 10.2147/IJN.S442520. eCollection 2024.
4
and its nano-mediated approach toward management of neurodegenerative disorders: A review.及其纳米介导的神经退行性疾病治疗方法:综述
Ibrain. 2023 Feb 7;9(1):111-123. doi: 10.1002/ibra.12091. eCollection 2023 Spring.
5
How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature.纳米治疗平台在神经胶质瘤中的作用:文献综述。
Int J Nanomedicine. 2023 Jul 3;18:3663-3694. doi: 10.2147/IJN.S414736. eCollection 2023.
6
The brain-penetrant cell-cycle inhibitor p28 sensitizes brain metastases to DNA-damaging agents.具有脑穿透性的细胞周期抑制剂p28可使脑转移瘤对DNA损伤剂敏感。
Neurooncol Adv. 2023 Apr 11;5(1):vdad042. doi: 10.1093/noajnl/vdad042. eCollection 2023 Jan-Dec.
7
Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine.生物医学科学中的生物源硒纳米颗粒:治疗诊断纳米医学的特性、当前趋势、新机遇与新挑战
Nanomaterials (Basel). 2023 Jan 19;13(3):424. doi: 10.3390/nano13030424.
8
Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience.神经纳米技术:应用神经科学中的诊断和治疗型纳米基策略。
Biomed Eng Online. 2023 Jan 2;22(1):1. doi: 10.1186/s12938-022-01062-y.
9
Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease.用于帕金森病中多巴胺和左旋多巴替代的聚合物纳米颗粒。
Nanoscale Adv. 2022 Nov 3;4(24):5233-5244. doi: 10.1039/d2na00524g. eCollection 2022 Dec 6.
10
Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today?用于神经退行性疾病的蛋白质和基因递送系统:我们如今处于什么阶段?
Pharmaceutics. 2022 Nov 10;14(11):2425. doi: 10.3390/pharmaceutics14112425.
Ther Deliv. 2012 Jul;3(7):875-87. doi: 10.4155/tde.12.55.
4
The shape of things to come: importance of design in nanotechnology for drug delivery.未来的形态:纳米技术中药物递送设计的重要性
Ther Deliv. 2012 Feb;3(2):181-94. doi: 10.4155/tde.11.156.
5
Drug penetration across the blood-brain barrier: an overview.药物透过血脑屏障:综述
Ther Deliv. 2010 Oct;1(4):535-62. doi: 10.4155/tde.10.37.
6
Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor.通过与识别转铁蛋白受体的肽连接将金纳米颗粒递送到大脑。
Biomaterials. 2012 Oct;33(29):7194-205. doi: 10.1016/j.biomaterials.2012.06.063. Epub 2012 Jul 15.
7
Copper and oxidative stress in the pathogenesis of Alzheimer's disease.铜与阿尔茨海默病发病机制中的氧化应激。
Biochemistry. 2012 Aug 14;51(32):6289-311. doi: 10.1021/bi3006169. Epub 2012 Jul 31.
8
Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems.基于 GSH 递药系统的神经退行性疾病治疗新进展。
Oxid Med Cell Longev. 2012;2012:240146. doi: 10.1155/2012/240146. Epub 2012 Jun 3.
9
Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats.载有控释左旋多巴甲酯/苄丝肼的纳米颗粒可改善大鼠左旋多巴诱导的运动障碍。
Int J Nanomedicine. 2012;7:2077-86. doi: 10.2147/IJN.S30463. Epub 2012 Apr 19.
10
Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools.阿尔茨海默病:生物学方面、治疗前景和诊断工具。
J Phys Condens Matter. 2012 Jun 20;24(24):244102. doi: 10.1088/0953-8984/24/24/244102. Epub 2012 May 18.